dihydroethidium has been researched along with drospirenone in 1 studies
| Studies (dihydroethidium) | Trials (dihydroethidium) | Recent Studies (post-2010) (dihydroethidium) | Studies (drospirenone) | Trials (drospirenone) | Recent Studies (post-2010) (drospirenone) |
|---|---|---|---|---|---|
| 308 | 3 | 99 | 530 | 177 | 262 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abreu, GR; Almeida, SA; Borgo, MV; Claudio, ER; Gouvea, SA; Graceli, JB; Moysés, MR; Podratz, PL; Romero, WG; Santos, RL; Silva, FB | 1 |
1 other study(ies) available for dihydroethidium and drospirenone
| Article | Year |
|---|---|
Hormonal therapy with estradiol and drospirenone improves endothelium-dependent vasodilation in the coronary bed of ovariectomized spontaneously hypertensive rats.
Topics: Androstenes; Animals; Blotting, Western; Bradykinin; Combined Modality Therapy; Coronary Vessels; Endothelium, Vascular; Estradiol; Estrogen Receptor alpha; Estrogens; Ethidium; Female; Femoral Artery; Hemodynamics; Hormone Replacement Therapy; Hypertension; Mineralocorticoid Receptor Antagonists; Nitric Oxide Synthase Type III; Ovariectomy; Oxidative Stress; Random Allocation; Rats; Rats, Inbred SHR; Vasodilation; Vasodilator Agents | 2016 |